San Diego, CA -- (SBWire) -- 12/07/2021 --Exicure, Inc is under investigation over potential securities laws violations in connection with certain financial statements.
Investors who purchased shares of Exicure, Inc. (NASDAQ: XCUR), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Exicure, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Chicago, IL based Exicure, Inc., a clinical-stage biotechnology company, develops therapeutics for neurology, immuno-oncology, inflammatory diseases, and genetic disorders based on its proprietary spherical nucleic acid (SNA) technology. On November 15, 2021, Exicure, Inc. filed a Form 12b-25 with the SEC stating that it could not timely file its quarterly report for the period ended September 30, 2021. It explained that the Company was investigating "a claim made by a former Company senior researcher regarding alleged improprieties that researcher claims to have committed with respect to the Company's XCUR-FXN preclinical program for the treatment of Friedreich's ataxia." Shares of Exicure, Inc. (NASDAQ: XCUR) declined from $1.30 per share in October 2021, to $0.41 per share on December 6, 2021.
Those who purchased shares of Exicure, Inc. (NASDAQ: XCUR) have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
Exicure, Inc. (NASDAQ:XCUR) Investor Investigation over Possible Violations of Securities Laws
An investigation for investors in Exicure, Inc. (NASDAQ:XCUR) shares over potential securities laws violations by Exicure, Inc. was announced.